NCT00344019 - Effects of Atorvastatin on Myonecrosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

January 31, 2009

Conditions

Coronary Disease

Interventions

DRUG

Placebo Oral Tablet

placebo pre-PCI for ACS

DRUG

Atorvastatin 80mg

atorvastatin 80 mg pre-angio/PCI

OTHER

Screening

Patients signed consent to be screened for eligibility for randomization to placebo vs. study drug (atorvastatin)

Trial Locations (1)

Beth Israel Deaconess Medical Center, Boston